452 related articles for article (PubMed ID: 18634778)
1. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
[TBL] [Abstract][Full Text] [Related]
2. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
[TBL] [Abstract][Full Text] [Related]
4. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress contributes to renovascular hypertension.
Oliveira-Sales EB; Dugaich AP; Carillo BA; Abreu NP; Boim MA; Martins PJ; D'Almeida V; Dolnikoff MS; Bergamaschi CT; Campos RR
Am J Hypertens; 2008 Jan; 21(1):98-104. PubMed ID: 18091751
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
Marçal DM; Rizzi E; Martins-Oliveira A; Ceron CS; Guimaraes DA; Gerlach RF; Tanus-Santos JE
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):35-44. PubMed ID: 21058008
[TBL] [Abstract][Full Text] [Related]
7. Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling.
Castro MM; Rizzi E; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
Matrix Biol; 2010 Apr; 29(3):194-201. PubMed ID: 19969080
[TBL] [Abstract][Full Text] [Related]
8. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
Ceron CS; Rizzi E; Guimaraes DA; Martins-Oliveira A; Cau SB; Ramos J; Gerlach RF; Tanus-Santos JE
Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
Castro MM; Rizzi E; Ceron CS; Guimaraes DA; Rodrigues GJ; Bendhack LM; Gerlach RF; Tanus-Santos JE
Nitric Oxide; 2012 Mar; 26(3):162-8. PubMed ID: 22327038
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
11. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress.
da Costa CA; de Oliveira PR; de Bem GF; de Cavalho LC; Ognibene DT; da Silva AF; Dos Santos Valença S; Pires KM; da Cunha Sousa PJ; de Moura RS; Resende AC
Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec; 385(12):1199-209. PubMed ID: 23052352
[TBL] [Abstract][Full Text] [Related]
12. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension.
Guimaraes DA; Rizzi E; Ceron CS; Oliveira AM; Oliveira DM; Castro MM; Tirapelli CR; Gerlach RF; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2011 May; 108(5):318-25. PubMed ID: 21176109
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
[TBL] [Abstract][Full Text] [Related]
15. Ca2+-activated K+ channels underlying the impaired acetylcholine-induced vasodilation in 2K-1C hypertensive rats.
Callera GE; Yogi A; Tostes RC; Rossoni LV; Bendhack LM
J Pharmacol Exp Ther; 2004 Jun; 309(3):1036-42. PubMed ID: 14978190
[TBL] [Abstract][Full Text] [Related]
16. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
Blascke de Mello MM; Parente JM; Schulz R; Castro MM
Vascul Pharmacol; 2019 May; 116():36-44. PubMed ID: 30339939
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.
Ceron CS; Castro MM; Rizzi E; Montenegro MF; Fontana V; Salgado MC; Gerlach RF; Tanus-Santos JE
Br J Pharmacol; 2010 May; 160(1):77-87. PubMed ID: 20331602
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
[TBL] [Abstract][Full Text] [Related]
20. Effects of renovascular hypertension on reproductive function in male rats.
Breigeiron MK; Lucion AB; Sanvitto GL
Life Sci; 2007 Apr; 80(17):1627-34. PubMed ID: 17316702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
